Global Infertility Treatment Market to reach USD 6,220.17 million by 2027 - Axiom MRC
Date: April 2021
The global infertility treatment market is rising at a significant pace, projected to rise at a CAGR of 7.31% during the estimated period from 2021 to 2027, starting from USD 3,824.25 million in 2020. The growth of the infertility treatment market is majorly driven by factors such as the decline in the overall fertility rate, an increase in the number of infertility clinics worldwide, technological advances, and rising public-private investment.
Media & consumables segment dominated the global market in 2020 based on product
On the basis of product, media & consumables segment held the largest share of infertility treatment market and is expected to reach USD 3033.65 million by 2027. Repeated buying of consumables or use and throw products drives the growth of the segment.
Assisted reproductive technology segment dominated the market, by procedure in 2020
Based on procedure, assisted reproductive technology dominated the market. It is estimated to register a CAGR value of 7.67% for the forecast period. Growing adoption of IVF treatments owing to its high success rates is the major factor responsible for the exponential growth of the segment.
By patient type, female infertility treatment dominated the global market in 2020
Based on patient type, the market is led by female infertility treatment. Delayed marriages and growing stress related disorders are the key growth factors.
North America dominated the global market in 2020
On the basis of region, North America held the largest share of the market owing to the presence of a well-established healthcare sector and various technological advancements.
The key competitors of this market include Cook Group Incorporated, Esco Micro Pte. Ltd., Genea Limited, Hamilton Throne, Ltd., Ihmedical A/S, Irvine Scientific (A Member of Jx Holdings Group), IVFTech Aps, Kitazato Corporation, Medgyn Products, Inc., The Baker Company, Inc., The Cooper Companies, Inc., Thermo Fisher Scientific, Vitrolife Ab, Zeiss Group among others.